Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab von Chaput, N., Lepage, P., Coutzac, C., Soularue, E., Le Roux, K., Monot, C., Boselli, L., Routier, E., Cassard, L., Collins, M., Vaysse, T., Marthey, L., Eggermont, A., Asvatourian, V., Lanoy, E., Mateus, C., Robert, C., Carbonnel, F.

Volltext

Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodies von Collins, M., Michot, J.M., Danlos, F.X., Mussini, C., Soularue, E., Mateus, C., Loirat, D., Buisson, A., Rosa, I., Lambotte, O., Laghouati, S., Chaput, N., Coutzac, C., Voisin, A.L., Soria, J.C., Marabelle, A., Champiat, S., Robert, C., Carbonnel, F.

Volltext

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab von Chaput, N., Lepage, P., Coutzac, C., Soularue, E., Le Roux, K., Monot, C., Boselli, L., Routier, E., Cassard, L., Collins, M., Vaysse, T., Marthey, L., Eggermont, A., Asvatourian, V., Lanoy, E., Mateus, C., Robert, C., Carbonnel, F.

Volltext

Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease von Marthey, L., Mateus, C., Mussini, C., Nachury, M., Nancey, S., Grange, F., Zallot, C., Peyrin-Biroulet, L., Rahier, J. F., Bourdier de Beauregard, M., Mortier, L., Coutzac, C., Soularue, E., Lanoy, E., Kapel, N., Planchard, D., Chaput, N., Robert, C., Carbonnel, F.

Volltext

1520P Perioperative treatment in resectable gastric cancer with spartalizumab combined with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT): The GASPAR phase II trial von Dos Santos, M., Lequesne, J., Piessen, G., Desgrippes, R., Guimbaud, R., Pernot, S., Bouche, O., Hiret, S., Soularue, E., Dahan, L., Tougeron, D., Borg, C., Le Sourd, S.M., Samalin-Scalzi, E., Tellier-Castera, M., Leconte, A., Clarisse, B.

Volltext

504O IMHOTEP Phase II trial of neoadjuvant pembrolizumab in dMMR/MSI tumors: Results of the colorectal cancer cohort von de la Fouchardiere, C., Zaanan, A., Cohen, R., Le Sourd, S.M., Tougeron, D., Soularue, E., Dubreuil, O., Williet, N., Samalin-Scalzi, E., Piessen, G., Hautefeuille, V., Jary, M., Ben Abdelghani, M., Evesque, L., Rochigneux, P., Blanc, E., Bibeau, F., DeMontfort, A., Coutzac, C.

Volltext

1448P IMHOTEP phase II trial of neoadjuvant pembrolizumab in dMMR/MSI localized cancers: Results of the digestive non-colorectal cancer cohorts von Fouchardiere, C. de la, Zaanan, A., Cohen, R., Le Sourd, S.M., Tougeron, D., Soularue, E., Dubreuil, O., Williet, N., Samalin-Scalzi, E., Piessen, G., Hautefeuille, V., Jary, M., Ben Abdelghani, M., Evesque, L., Rochigneux, P., Blanc, E., Bibeau, F., DeMontfort, A., Coutzac, C.

Volltext

496TiP Randomised phase II study evaluating trifluridine/tipiracil (FTD/TPI) plus oxaliplatin ± nivolumab versus FOLFOX ± nivolumab in patients with HER2-negative locally advanced,... von de la Fouchardiere, C., Chabaud, S., Perrier, H., Ammarguellat, H., Jestin, V., Olesinski, J., Toullec, C., Aparicio, T., Ben Abdelghani, M., Bouche, O., Coutzac, C., Dubreuil, O., Evesque, L., Muller, M., Poureau, P-G., Soularue, E., Tougeron, D., Zaanan, A., De Sousa Carvalho, N., Botsen, D.

Volltext

440P Response to BRAF inhibitors combined with anti-EGFR after previous anti-EGFR exposure for BRAF V600E mutant metastatic colorectal cancer patients von Hafliger, E., Boccaccino, A., El-Khoury, R., Perret, A., Pietrantonio, F., Pilla, L., Lecomte, T., Scartozzi, M., Soularue, E., Salvatore, L., Bourgeois, V., Salati, M., Vaillant, J.N., Gallois, C., Lonardi, S., Cremolini, C., Taieb, J.

Volltext

Baseline gut microbiota in metastatic melanoma patients treated with ipilimumab: Relation with clinical response and colitis von Chaput, N., Lepage, P., Coutzac, C., Soularue, E., Asvatourian, V., Lanoy, E., Mateus, C., Carbonnel, F., Robert, C.

Volltext

52P Modified FOLFIRINOX versus CISGEM as first-line chemotherapy for advanced biliary tract cancer: Results of AMEBICA PRODIGE 38 randomized phase II trial von Phelip, J.M., Desrame, J., Edeline, J., Barbier, E., Terrebonne, E., Michel, P., Perrier, H., Dahan, L., Bourgeois, V., Khemissa Akouz, F., Soularue, E., Lebrun, V. Ly, Molin, Y., Lecomte, T., Ghiringhelli, F., Coriat, R., Louafi, S., Neuzillet, C., Manfredi, S., Malka, D.

Volltext

P366 Long-term evolution of gastrointestinal immune-related adverse events (GI-IrAE) induced by immune checkpoint inhibitors (ICI) von de Malet, A, Antoni, G, Soularue, E, Collins, M, Marthey, L, Vaysse, T, Mateus, C, Robert, C, Carbonnel, F

Volltext

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab von Chaput, N, Lepage, P, Coutzac, C, Soularue, E, Le Roux, K, Monot, C, Boselli, L, Routier, E, Cassard, L, Collins, M, Vaysse, T, Marthey, L, Eggermont, A, Asvatourian, V, Lanoy, E, Mateus, C, Robert, C, Carbonnel, F

Volltext

P315 Gastrointestinal immune related adverse events associated with programmed-Death 1 blockade von Collins, M., Michot, J.-M., Danlos, F.-X., Champiat, S., Mussini, C., Soularue, E., Mateus, C., Loirat, D., Buisson, A., Rosa, I., Lambotte, O., Laghouati, S., Voisin, A.-L., Soria, J.-C., Marabelle, A., Robert, C., Carbonnel, F.

Volltext

Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodies von Collins, M, Michot, J M, Danlos, F X, Mussini, C, Soularue, E, Mateus, C, Loirat, D, Buisson, A, Rosa, I, Lambotte, O, Laghouati, S, Chaput, N, Coutzac, C, Voisin, A L, Soria, J C, Marabelle, A, Champiat, S, Robert, C, Carbonnel, F

Volltext

Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study von Phelip, Jean Marc, Desrame, Jérôme, Edeline, Julien, Barbier, Emilie, Terrebonne, Eric, Michel, Pierre, Perrier, Hervé, Dahan, Laetitia, Bourgeois, Vincent, Akouz, Faiza Khemissa, Soularue, Emilie, Ly, Valérie Lebrun, Molin, Yann, Lecomte, Thierry, Ghiringhelli, François, Coriat, Romain, Louafi, Samy, Neuzillet, Cindy, Manfredi, Sylvain, Malka, David

Volltext

Novel gene transcripts preferentially expressed in human muscles revealed by quantitative hybridization of a high density cDNA array von Piétu, G, Alibert, O, Guichard, V, Lamy, B, Bois, F, Leroy, E, Mariage-Sampson, R, Houlgatte, R, Soularue, P, Auffray, C

Volltext

Continuum of overlapping clones spanning the entire human chromosome 21q von Chumakov, Ilya, Rigault, Philippe, Guillou, Sophie, Ougen, Pierre, Billaut, Alain, Guasconi, Ghislaine, Gervy, Patricia, LeGall, Isabelle, Soularue, Pascal, Grinas, Laurent, Bougueleret, Lydie, Bellanné-Chantelot, Christine, Lacroix, Bruno, Barillot, Emmanuel, Gesnouin, Philippe, Pook, Stuart, Vaysseix, Guy, Frelat, Gerard, Schmitz, Annette, Sambucy, Jean-Luc, Bosch, Assumpcio, Estivill, Xavier, Weissenbach, Jean, Vignal, Alain, Riethman, Harold, Cox, David, Patterson, David, Gardiner, Kathleen, Hattori, Masahira, Sakaki, Yoshiyuki, Ichikawa, Hitoshi, Ohki, Misao, Paslier, Denis Le, Heilig, Roland, Antonarakis, Stylianos, Cohen, Daniel

Volltext

A YAC contig map of the human genome von Chumakov, I M, Rigault, P, Le Gall, I, Bellanné-Chantelot, C, Billault, A, Guillou, S, Soularue, P, Guasconi, G, Poullier, E, Gros, I

Volltext

Isolation of chromosome 21-specific yeast artificial chromosomes from a total human genome library von Chumakov, I.M, Le Gall, I, Billault, A, Ougen, P, Soularue, P, Guillou, S, Rigault, P, Hui, H, Tand, M.F. de, Barillot, E

Volltext